GLAXF GSK PLC
- 22.800
- +0.030+0.13%
GSK PLC News
GSK PLC's Dividend Analysis
GSK PLC To Go Ex-Dividend On May 16th, 2024 With 0.18872 USD Dividend Per Share
May 15th - $GSK PLC(GLAXF.US)$ is trading ex-dividend on May 16th, 2024. Shareholders of record on May 17th, 2024 will receive 0.18872 USD dividend per share on July 11th, 2024. The ex-dividend da
GSK Plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK Invests in BioVersys to Speed Development of Potential Tuberculosis Treatment
GSK (GSK) and BioVersys have expanded their collaboration to speed up development of alpibectir, a potential tuberculosis treatment, BioVersys said Tuesday. As part of the deal, GSK will take a 12.3 m
BioVersys And GSK Boost Fight Against Tuberculosis With Expanded Partnership And Series C Funding Increase By CHF 12.3M
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C fina
GSK Plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by USD5 to US
GSK PLC To Go Ex-Dividend On May 16th, 2024 With 0.18869 USD Dividend Per Share
May 2nd - $GSK PLC(GLAXF.US)$ is trading ex-dividend on May 16th, 2024. Shareholders of record on May 17th, 2024 will receive 0.188 USD dividend per share on July 11th, 2024. The ex-dividend date
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0921 ET - GSK's CEO Emma Walmsley says in a press call that sh
GSK Raises Profit Guidance as Vaccine Demand Grows
GSK Q1 Core Earnings, Revenue Advance; 2024 Outlook Lifted -- Shares Up Pre-Bell
GSK (GSK) reported Q1 core earnings Wednesday of 0.431 British pounds ($0.54) per share, up from 0.37 pounds a year earlier. Analysts polled by Capital IQ expected 0.37 pounds. Turnover for the quarte
Trending: GSK Lifts Profit Guidance On Earnings Beat
0922 GMT - GSK is among the most mentioned companies across news items over the past twelve hours after it lifted its profit guidance for the year, according to Factiva data. The British pharmaceutica
Trending Tickers: Amazon, AMD, GSK and Aston Martin
GSK Results Are Solid Despite Lower Expected Sales, Arexvy Miss -- Market Talk
0819 GMT - GSK's core earnings per share beat and full-year guidance lift outweigh expected lower sales in the second half and a sales miss for its respiratory syncytial virus vaccine Arexvy, Citi ana
GSK Raises Outlook for 2024 as Higher First-quarter Turnover Boosts Confidence
Thanks to turnover growth in the first quarter led by business momentum across all product areas, GSK (GSK.L) is now more bullish regarding its growth prospects for 2024, according to its Wednesday re
GSK Lifts Guidance After Turnover Beats Expectations
By Helena Smolak GSK lifted its full-year guidance after first-quarter turnover rose and beating expectations, helped by higher sales in its vaccines and specialty medicines segment. The British pha
GSK Posts Lower Q1 Attributable Profit; Turnover Up
GSK (GSK.L) said Wednesday that profit for the first quarter decreased while turnover increased year over year. Profit attributable to shareholders for the three months ended March 31 was 1.05 billion
GSK PLC Sees 2024 Turnover Growth in the Upper Range of 5%-7%
GSK PLC Sees 2024 Turnover Growth in the Upper Range of 5%-7%
GSK PLC Raises 2024 View
GSK PLC Raises 2024 View
Analysis
Price Target
No Data
